Celularity (CELU) Inventory Average (2021 - 2025)
Celularity's (CELU) quarterly Inventory Average came in at $6.5 million in Q4 2025, down 40.65% year-over-year from $11.0 million in Q4 2024, and down 38.91% quarter-over-quarter from $10.7 million in Q3 2025.
Analysis
Celularity (CELU) Inventory Average (2021 - 2025) Analysis & Trends
Celularity (CELU) has reported Inventory Average for 5 consecutive years, with $6.5 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Inventory Average fell 40.65% year-over-year to $6.5 million in Q4 2025; TTM through Dec 2025 was $6.5 million, a 40.65% decrease from a year earlier, with the FY2025 full-year figure at $10.8 million, down 46.76% from the prior year.
- Inventory Average was $6.5 million for Q4 2025 at Celularity, down from $10.7 million in the prior quarter.
- Over five years, Inventory Average peaked at $19.7 million in Q2 2022 and troughed at $3.3 million in Q2 2024.
- A 5-year average of $9.9 million and a median of $10.7 million in 2025 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average plunged 71.5% in 2023 and jumped 313.97% in 2025, its largest moves.
- Over 5 years, Inventory Average stood at $7.6 million in 2021, then tumbled by 31.05% to $5.3 million in 2022, then soared by 159.26% to $13.7 million in 2023, then dropped by 19.69% to $11.0 million in 2024, then tumbled by 40.65% to $6.5 million in 2025.
- The last three Inventory Average figures came in at $6.5 million (Q4 2025), $10.7 million (Q3 2025), and $13.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | 44.10 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | 56.98 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 39.30 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 17.49 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 952.69 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 18.37 Mn |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | 6.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.52 Mn |
| Sep 30, 2025 | 10.67 Mn |
| Jun 30, 2025 | 13.69 Mn |
| Mar 31, 2025 | 16.78 Mn |
| Dec 31, 2024 | 10.98 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 13.06 Mn |
| Dec 31, 2023 | 13.67 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | 5.61 Mn |
| Mar 31, 2023 | 5.40 Mn |
| Dec 31, 2022 | 5.27 Mn |
| Sep 30, 2022 | 14.95 Mn |
| Jun 30, 2022 | 19.69 Mn |
| Mar 31, 2022 | 12.13 Mn |
| Dec 31, 2021 | 7.65 Mn |